Assisted reproductive technology in China: compliance and non-compliance - PubMed (original) (raw)

Review

Assisted reproductive technology in China: compliance and non-compliance

Jie Qiao et al. Transl Pediatr. 2014 Apr.

Abstract

According to the WHO, infertility and sterility will be the third-most serious disease worldwide in the 21st century, after cancer and cardiovascular diseases. In contrast to developed countries, assisted reproductive technology (ART) were not offered in China until the mid-1980s with the first in vitro fertilization (IVF) infant born in Taiwan in 1985, then Hong Kong in 1986, and mainland China in 1988, respectively. Since those inceptions, the practice of ART in China has evoked a variety of social, cultural, political and one-child policy responses that have resulted in restrictions on the number of IVF cycles performed annually. According to recent survey, an estimate 40-50 million women and 45 million men suffered from infertility, which is estimated that more than ten million Chinese infertile couples require ART treatment. However, it has limited access to ART facilities, many of them may not have a child are whirling to all types of fertility therapies. Exposure to radiation, pesticides and other environmental pollutants, work-related stress and unhealthy lifestyles are believed to contribute to the increasing incidence of infertility in China. The aim of this first report is to provide China nationwide ART data and government policy in compliance and non-compliance, particularly related to family plan policy in China.

Keywords: Assisted reproductive technology (ART); China; in vitro fertilization (IVF); infertility; policy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1

Mainland China assisted reproductive technology (ART) centers (the number) and sperm bank (SB) distributions [2011].

Similar articles

• In vitro fertilization and multiple pregnancies: an evidence-based analysis.
  Medical Advisory Secretariat. Medical Advisory Secretariat. Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1. Ont Health Technol Assess Ser. 2006. PMID: 23074488 Free PMC article.
• Effectiveness of a mixed lifestyle program in couples undergoing assisted reproductive technology: a study protocol.
  Malekpour P, Hasanzadeh R, Javedani Masroor M, Chaman R, Motaghi Z. Malekpour P, et al. Reprod Health. 2023 Aug 1;20(1):112. doi: 10.1186/s12978-023-01652-6. Reprod Health. 2023. PMID: 37528465 Free PMC article.
• Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016.
  Bai F, Wang DY, Fan YJ, Qiu J, Wang L, Dai Y, Song L. Bai F, et al. Hum Reprod. 2020 Feb 29;35(2):446-452. doi: 10.1093/humrep/dez245. Hum Reprod. 2020. PMID: 32020190
• Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century.
  Inhorn MC, Patrizio P. Inhorn MC, et al. Hum Reprod Update. 2015 Jul-Aug;21(4):411-26. doi: 10.1093/humupd/dmv016. Epub 2015 Mar 22. Hum Reprod Update. 2015. PMID: 25801630 Review.
• IVF and other ART in low- and middle-income countries: a systematic landscape analysis.
  Chiware TM, Vermeulen N, Blondeel K, Farquharson R, Kiarie J, Lundin K, Matsaseng TC, Ombelet W, Toskin I. Chiware TM, et al. Hum Reprod Update. 2021 Feb 19;27(2):213-228. doi: 10.1093/humupd/dmaa047. Hum Reprod Update. 2021. PMID: 33238297 Free PMC article. Review.

Cited by

• Religious aspects of assisted reproduction.
  Sallam HN, Sallam NH. Sallam HN, et al. Facts Views Vis Obgyn. 2016 Mar 28;8(1):33-48. Facts Views Vis Obgyn. 2016. PMID: 27822349 Free PMC article. Review.
• Uterine factors modify the association between embryo transfer depth and clinical pregnancy.
  Sun X, Cai J, Liu L, Chen H, Jiang X, Ren J. Sun X, et al. Sci Rep. 2022 Aug 22;12(1):14269. doi: 10.1038/s41598-022-18636-4. Sci Rep. 2022. PMID: 35995967 Free PMC article.
• Cumulative live birth rates of in vitro fertilization/intracytoplasmic sperm injection after multiple complete cycles in China.
  Huang L, Lu Q, Du J, Lv H, Tao S, Chen S, Li X, Han X, Zhou K, Xu B, Liu X, Ma H, Xia Y, Jin G, Shen H, Ling X, Hu Z, Tan J, Diao F. Huang L, et al. J Biomed Res. 2020 Aug 14;34(5):361-368. doi: 10.7555/JBR.34.20200035. J Biomed Res. 2020. PMID: 32981896 Free PMC article.
• Urinary Organophosphate Metabolite Concentrations and Pregnancy Outcomes among Women Conceiving through in Vitro Fertilization in Shanghai, China.
  Hu P, Vinturache A, Li H, Tian Y, Yuan L, Cai C, Lu M, Zhao J, Zhang Q, Gao Y, Liu Z, Ding G. Hu P, et al. Environ Health Perspect. 2020 Sep;128(9):97007. doi: 10.1289/EHP7076. Epub 2020 Sep 30. Environ Health Perspect. 2020. PMID: 32997523 Free PMC article.
• Implications of lifestyle factors on male reproductive health.
  Rotimi DE, Singh SK. Rotimi DE, et al. JBRA Assist Reprod. 2024 Jun 1;28(2):320-330. doi: 10.5935/1518-0557.20240007. JBRA Assist Reprod. 2024. PMID: 38289202 Free PMC article. Review.

References

1. 1. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;2:366. - PubMed
2. 1. Inhorn MC. Right to assisted reproductive technology: overcoming infertility in low-resource countries. Int J Gynaecol Obstet 2009;106:172-4. - PubMed
3. 1. Gallagher J. Five millionth “test tube baby”, BBC News 2012; July 1. Available online: http://www.bbc.com/news/health-18649582
4. 1. Available online: www.chinaview.cn. China’s first test-tube baby enters college. China View 2007; August 30.
5. 1. Available online: http://bike.baidu.com/view/976666.htm Test tube baby technology.

Publication types

LinkOut - more resources

• Full Text Sources

  • AME Publishing Company
  • Europe PubMed Central
  • PubMed Central